Lip Squamous Cell Carcinoma: A Conceptual Framework for Integrating Molecular, Immune and Microenvironmental Drivers
Open Access
- 25 October 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (21) , 9528
Abstract
Lip squamous cell carcinoma (LSCC) is a distinct subtype of head and neck squamous cell carcinoma strongly associated with ultraviolet (UV) radiation exposure and characterized by unique molecular, immune, and microenvironmental features. Although UV-induced photodamage represents the principal initiating event, increasing evidence indicates that LSCC progression results from complex interactions among genetic and epigenetic alterations, dysregulated signaling pathways, chronic inflammation, immune dysregulation, host–microbiome dynamics, and tumor microenvironment (TME) remodeling. Recent advances have expanded the traditional view of LSCC by highlighting the contributions of UV-induced DNA damage, tumor protein p53 (TP53) alterations, epigenetic reprogramming, aberrant activation of key signaling pathways, and progressive immune escape mechanisms. In parallel, growing attention has focused on the role of cancer-associated fibroblasts (CAFs), stromal remodeling, microbial dysbiosis, and disruption of the microbiome–immune–metabolic axis as important modulators of disease progression and biological heterogeneity. Emerging biomarkers, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), epigenetic signatures, liquid-biopsy analytes, immune-related markers, and microbiome-associated profiles, together with artificial intelligence (AI)-based analytical approaches, are creating new opportunities for diagnosis, risk stratification, disease monitoring, and precision oncology. Rather than providing a conventional descriptive overview, this review proposes an integrated conceptual framework in which molecular, immune, microbial, and microenvironmental drivers interact through continuous bidirectional crosstalk to shape LSCC initiation, progression, therapeutic responsiveness, and clinical heterogeneity. This system-oriented perspective may provide a foundation for future biomarker-guided and biologically informed approaches to LSCC management.Keywords
Funding Information
- University of L’Aquila (VITALITY06_CIFONE)
This publication has 48 references indexed in Scilit:
- Circulating lncRNA as Biomarkers and Therapeutics in Oral Cancer: Silent Scripts with Loud ImpactMolecular Biology Reports, 2026
- Subsite- and histology-specific epidemiology of head and neck cancers in Japan from 2016 to 2019: an application of a new classification of rare cancersInternational Journal of Clinical Oncology, 2026
- Understanding the potential of probiotics in oral cancer prevention: a short review on microbial modulationDiscover Oncology, 2025
- Different densities of Langerhans cells among oral squamous cell carcinoma, lip squamous cell carcinoma and oral potentially malignant disorders: Systematic review and network meta-analysisArchives of Oral Biology, 2025
- Carcinogenetic mechanisms employed by the oral microbiome: A narrative reviewThe American Journal of the Medical Sciences, 2025
- Clinicopathological Analysis of Actinic Cheilitis: A Systematic Review with Meta-analysesHead and Neck Pathology, 2023
- Microbial dysbiosis in oral squamous cell carcinoma: A systematic review and meta-analysisHeliyon, 2023
- The Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Oral Cancer ManagementProbiotics and Antimicrobial Proteins, 2022
- Lip and Oral Cavity Squamous Cell CarcinomaHematology/Oncology Clinics of North America, 2021
- A short review on DNA damage and repair effects in lip cancerHematology/Oncology and Stem Cell Therapy, 2021